Green Leaf Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 14 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 14.04%
- Profit Growth -1.31%
- Ebitda -61.82%
- Net Worth 11.96%
- Total Assets 44.25%
About Green Leaf Life Sciences
Green Leaf Life Sciences Private Limited (GLLSPL) is a Private Limited Indian Non-Government Company incorporated in India on 18 February 2010 and has a history of 14 years and 11 months. Its registered office is in Jhujhunu, Rajasthan, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Ravikant and Vandana serve as directors at the Company.
Company Details
- Location
Jhujhunu, Rajasthan, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U24232RJ2010PTC031020
- Company No.
031020
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Feb 2010
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Jaipur
Industry
What products or services does Green Leaf Life Sciences Private Limited offer?
Green Leaf Life Sciences Private Limited offers a wide range of products and services, including Pain Relief Drugs & Pharmaceuticals, Aceclofenac, Digestive System Drugs & Medicines, Antacid Drugs, Nutraceuticals & Dietary Supplements, Multivitamin Syrup & Drops, Mineral Supplement, Common Disease Medicines, Pharmaceutical Medicine, Anti Infective Drugs & Medicines.
Who are the key members and board of directors at Green Leaf Life Sciences?
Financial Performance of Green Leaf Life Sciences.
Green Leaf Life Sciences Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 14.04% increase. The company also saw a slight decrease in profitability, with a 1.31% decrease in profit. The company's net worth Soared by an impressive increase of 11.96%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Green Leaf Life Sciences?
In 2017, Green Leaf Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Green Leaf Life Sciences?
Unlock and access historical data on people associated with Green Leaf Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Green Leaf Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Green Leaf Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
